node,neighbor,type
10.1002/cbdv.200800342,"Cytotoxic activity against human leukemia (MOLT-4), melanoma (MDA-MB-435), colon (HCT-8), and glyoblastoma (SF-295) cancer cell lines, and against L-929 (normal fibroblasts).",doi_bioActivity
10.1002/cbdv.200800342,Cytotoxic activity against human tumor cell lines.,doi_bioActivity
10.1002/cbdv.200800342,Cytotoxic activity against human tumor cell lines.,doi_bioActivity
10.1002/cbdv.200800342,Cytotoxic activity against human tumor cell lines.,doi_bioActivity
10.1002/cbdv.200800342,Cytotoxic activity against human tumor cell lines.,doi_bioActivity
10.1002/cbdv.200800342,"Strongest cytotoxicity against all tumor cell lines tested, compared to normal L-929 cells. Comparable with the positive control doxorubicin.",doi_bioActivity
10.1002/cbdv.200800342,"No cytotoxic activity to cancer cells, indicating that the presence of these CO groups at C(18) and C(19) is incompatible with the cytotoxic activity. Derived from degradation of casearin X in CDCl3.",doi_bioActivity
10.1002/hlca.200890147,Moderate antifungal activities against Candida albicans and C. krusei,doi_bioActivity
10.1002/hlca.200890147,Moderate antifungal activities against Candida albicans and C. krusei,doi_bioActivity
10.1002/hlca.200890147,Moderate antifungal activities against Candida albicans and C. krusei,doi_bioActivity
10.1002/hlca.200890147,Moderate antifungal activities against Candida albicans and C. krusei,doi_bioActivity
10.1002/hlca.200890147,Moderate antifungal activities against Candida albicans and C. krusei,doi_bioActivity
10.1002/ps.1278,"Moderate larval weight loss in Spodoptera frugiperda after 10 days of treatment, suggesting some antifeedant or toxicity effect, but further details are not mentioned",doi_bioActivity
10.1002/ps.1278,Possible feeding deterrence causing larval weight loss in Spodoptera frugiperda,doi_bioActivity
10.1002/ps.1278,"High larval mortality in Spodoptera frugiperda, suggest insecticidal or antifeedant properties",doi_bioActivity
10.1002/ps.1278,High larval mortality in Spodoptera frugiperda,doi_bioActivity
10.1002/ps.1278,Possible feeding deterrence causing larval weight loss in Spodoptera frugiperda similar to tannin's bioactivity,doi_bioActivity
10.1002/ps.478,"Growth inhibiting activity by stomach ingesting, insecticidal against Anticarsia gemmatalis and Spodoptera frugiperda",doi_bioActivity
10.1016/0031-9422(81)80027-1,Anesthetic action on the mucous membranes of the mouth,doi_bioActivity
10.1016/0031-9422(81)80027-1,Responsible for anesthetic activity,doi_bioActivity
10.1016/0040-4020(95)00254-6,Active in a mechanism-based DNA-modifying yeast assay and cytotoxic in Vero monkey and Chinese hamster ovary cell assays,doi_bioActivity
10.1016/0040-4020(95)00254-6,Moderately active in Vero monkey and Chinese hamster ovary cell cytotoxicity assays,doi_bioActivity
10.1016/0040-4020(95)00254-6,Unknown specific bioactivity from the provided data,doi_bioActivity
10.1016/0040-4020(95)00254-6,Assumed bioactive but no specific bioactivity profile provided,doi_bioActivity
10.1016/0040-4020(95)00254-6,Assumed bioactive but no specific bioactivity profile provided,doi_bioActivity
10.1016/0040-4020(95)00254-6,Unknown specific bioactivity from the provided data,doi_bioActivity
10.1016/0040-4020(95)00254-6,Assumed bioactive but no specific bioactivity profile provided,doi_bioActivity
10.1016/S0031-9422(00)00477-5,antioxidant activity,doi_bioActivity
10.1016/S0031-9422(00)00477-5,antioxidant activity,doi_bioActivity
10.1016/S0031-9422(00)00477-5,inhibiting the bleaching of β-carotene,doi_bioActivity
10.1016/S0031-9422(00)00477-5,antioxidant activity,doi_bioActivity
10.1016/S0031-9422(00)00477-5,inhibiting the bleaching of β-carotene,doi_bioActivity
10.1016/S0031-9422(00)00477-5,inhibiting the bleaching of β-carotene,doi_bioActivity
10.1016/S0031-9422(01)00431-9,Antifungal activity against Cladosporium sphaerospermum,doi_bioActivity
10.1016/S0031-9422(01)00431-9,Antifungal activity against Cladosporium sphaerospermum,doi_bioActivity
10.1016/S0031-9422(01)00431-9,Antifungal activity against Cladosporium cladosporioides,doi_bioActivity
10.1016/S0031-9422(01)00431-9,Antifungal activity against Cladosporium cladosporioides,doi_bioActivity
10.1016/S0031-9422(01)00431-9,Antifungal activity against Cladosporium sphaerospermum,doi_bioActivity
10.1016/S0031-9422(01)00431-9,Antifungal activity against Cladosporium cladosporioides,doi_bioActivity
10.1016/S0031-9422(01)00431-9,Antifungal activity against Cladosporium cladosporioides,doi_bioActivity
10.1016/S0031-9422(01)00431-9,Antifungal activity against Cladosporium cladosporioides,doi_bioActivity
10.1016/S0031-9422(01)00431-9,Antifungal activity against Cladosporium sphaerospermum and Cladosporium cladosporioides,doi_bioActivity
10.1016/S0031-9422(01)00431-9,Antifungal activity against Cladosporium cladosporioides,doi_bioActivity
10.1016/S0031-9422(01)00431-9,Antifungal activity against Cladosporium cladosporioides,doi_bioActivity
10.1016/S0031-9422(01)00431-9,Antifungal activity against Cladosporium cladosporioides,doi_bioActivity
10.1016/S0031-9422(01)00431-9,Antifungal activity against Cladosporium cladosporioides,doi_bioActivity
10.1016/S0031-9422(03)00153-5,In vitro activity against trypomastigote forms of Trypanosoma cruzi with IC50 value of 59.0 mg/mL,doi_bioActivity
10.1016/S0031-9422(03)00153-5,In vitro activity against trypomastigote forms of Trypanosoma cruzi with IC50 value of 90.2 mg/mL,doi_bioActivity
10.1016/S0031-9422(03)00153-5,In vitro activity against trypomastigote forms of Trypanosoma cruzi,doi_bioActivity
10.1016/S0031-9422(97)00238-0,Antifungal activity against C. cladosporioides and C. esphaerospermum,doi_bioActivity
10.1016/S0031-9422(97)00238-0,Antifungal activity against C. cladosporioides and C. esphaerospermum,doi_bioActivity
10.1016/S0031-9422(97)00238-0,Antifungal activity against C. cladosporioides and C. esphaerospermum,doi_bioActivity
10.1016/S0031-9422(97)00238-0,Antifungal activity against C. cladosporioides and C. esphaerospermum,doi_bioActivity
10.1016/S0031-9422(98)00249-0,"DNA-damaging activity, selective activity in the Rad 52Y and RS 321 yeast assay compared with the wild type Rad+ strain",doi_bioActivity
10.1016/S0031-9422(98)00249-0,"DNA-damaging activity, selective activity in the Rad 52Y and RS 321 yeast assay compared with the wild type Rad+ strain",doi_bioActivity
10.1016/S0031-9422(98)00249-0,"DNA-damaging activity, selective activity in the Rad 52Y and RS 321 yeast assay compared with the wild type Rad+ strain",doi_bioActivity
10.1016/j.biortech.2010.01.041,Weak inhibition of protease (subtilisin and pepsin),doi_bioActivity
10.1016/j.biortech.2010.01.041,Weak inhibition of protease (subtilisin and pepsin),doi_bioActivity
10.1016/j.biortech.2010.01.041,Weak inhibition of protease (subtilisin and pepsin),doi_bioActivity
10.1016/j.biortech.2010.01.041,Weak inhibition of protease (subtilisin and pepsin),doi_bioActivity
10.1016/j.biortech.2010.01.041,Weak inhibition of protease (subtilisin and pepsin),doi_bioActivity
10.1016/j.biortech.2010.01.041,Weak inhibition of protease (subtilisin and pepsin),doi_bioActivity
10.1016/j.chroma.2009.02.066,Inhibition of symbiotic fungus (Leucoagaricus gongylophorus) of leaf-cutting ant (Atta sexdens rubropilosa),doi_bioActivity
10.1016/j.chroma.2009.02.066,"Not explicitly stated in the provided content, further studies are mentioned for identification, mechanism, and transformation",doi_bioActivity
10.1016/j.chroma.2009.02.066,Not explicitly mentioned,doi_bioActivity
10.1016/j.chroma.2009.02.066,Not explicitly mentioned,doi_bioActivity
10.1016/j.jep.2007.09.020,"anti-inflammatory, potential preventive effect against kidney stone",doi_bioActivity
10.1016/j.jep.2007.09.020,"anti-inflammatory, potential preventive effect against kidney stone",doi_bioActivity
10.1016/j.jep.2007.09.020,"anti-inflammatory, preventive effect against kidney stone",doi_bioActivity
10.1016/j.jep.2007.09.020,"anti-inflammatory, preventive effect against kidney stone",doi_bioActivity
10.1016/j.jep.2007.09.020,"anti-inflammatory, antinociceptive and antioxidant",doi_bioActivity
10.1016/j.jep.2007.09.020,"anti-inflammatory, antinociceptive and antioxidant",doi_bioActivity
10.1016/j.jep.2007.09.020,"anti-inflammatory, antinociceptive and antioxidant",doi_bioActivity
10.1016/j.jep.2007.09.020,"anti-inflammatory, antinociceptive and antioxidant",doi_bioActivity
10.1016/j.jfca.2003.09.013,Antioxidant; free radical scavenging activity,doi_bioActivity
10.1016/j.jfca.2003.09.013,Antioxidant; free radical scavenging activity,doi_bioActivity
10.1016/j.jfca.2003.09.013,Antioxidant; free radical scavenging activity,doi_bioActivity
10.1016/j.jfca.2003.09.013,Antioxidant; free radical scavenging activity,doi_bioActivity
10.1016/j.jfca.2003.09.013,Antioxidant; free radical scavenging activity,doi_bioActivity
10.1016/j.jfca.2003.09.013,Antioxidant,doi_bioActivity
10.1016/j.micres.2004.06.003,"{'M. luteus': 'The MIC values against M. luteus was 99 mg/mL.', 'S. aureus': 'The MIC values against S. aureus was 137 mg/mL.'}",doi_bioActivity
10.1016/j.phytochem.2005.04.043,Weak in vitro antifungal activity against Cladosporium sphaerospermum and Cladosporioides.,doi_bioActivity
10.1016/j.phytochem.2005.04.043,"Weak in vitro antifungal activity against Cladosporium sphaerospermum and Cladosporioides, induces cell proliferation: 70% on HeLa cells and 25% on CHO cells.",doi_bioActivity
10.1016/j.phytochem.2005.04.043,Not described.,doi_bioActivity
10.1016/j.phytochem.2005.04.043,No antifungal activity noted.,doi_bioActivity
10.1016/j.phytochem.2005.06.019,Inactive in DPPH free radical scavenging activity,doi_bioActivity
10.1016/j.phytochem.2005.06.019,Weak free radical scavenging activity towards DPPH,doi_bioActivity
10.1016/j.phytochem.2005.06.019,"Strong antioxidant activity, comparable with that of caffeic acid",doi_bioActivity
10.1016/j.phytochem.2005.06.019,"Strong antioxidant activity, comparable with that of caffeic acid",doi_bioActivity
10.1016/j.phytochem.2005.06.019,Weak free radical scavenging activities towards DPPH,doi_bioActivity
10.1021/jf00030a035,Moderate cytotoxic activity against BT-20 breast and HeLa epithelioid cervix carcinoma cells,doi_bioActivity
10.1021/jf00030a035,Moderate cytotoxic activity against BT-20 breast and HeLa epithelioid cervix carcinoma cells,doi_bioActivity
10.1021/jf00030a035,Moderate cytotoxic activity against BT-20 breast and HeLa epithelioid cervix carcinoma cells,doi_bioActivity
10.1021/jf00030a035,Moderate cytotoxic activity against BT-20 breast and HeLa epithelioid cervix carcinoma cells,doi_bioActivity
10.1021/jf00030a035,Moderate cytotoxic activity against BT-20 breast and HeLa epithelioid cervix carcinoma cells,doi_bioActivity
10.1021/jf00030a035,Moderate cytotoxic activity against BT-20 breast and HeLa epithelioid cervix carcinoma cells,doi_bioActivity
10.1021/jf60217a066,"Anesthetic properties, flavor similar to anise seed oil",doi_bioActivity
10.1021/jf60217a066,"Potent anesthetic, likely responsible for the pharmacological activity of plant infusions",doi_bioActivity
10.1021/np0103970,Weak inhibitory activity against trypomastigote forms of Trypanosoma cruzi,doi_bioActivity
10.1021/np0103970,Weak inhibitory activity against trypomastigote forms of Trypanosoma cruzi,doi_bioActivity
10.1021/np0103970,Inactive in brine shrimp lethality test,doi_bioActivity
10.1021/np0103970,Inactive in brine shrimp lethality test,doi_bioActivity
10.1021/np0103970,Inactive in brine shrimp lethality test,doi_bioActivity
10.1021/np0303963,DNA-damaging activity on mutant yeast strains of Saccharomyces cerevisiae,doi_bioActivity
10.1021/np0303963,Inactive on DNA-damaging activity assay,doi_bioActivity
10.1021/np0303963,Inactive on DNA-damaging activity assay,doi_bioActivity
10.1021/np0303963,DNA-damaging activity on mutant yeast strains of Saccharomyces cerevisiae,doi_bioActivity
10.1021/np060254j,Anxiolytic effects similar to diazepam in the elevated T-maze test in mice,doi_bioActivity
10.1021/np060254j,Anxiolytic effects similar to diazepam in the elevated T-maze test in mice,doi_bioActivity
10.1021/np060254j,Anxiolytic effects similar to diazepam in the elevated T-maze test in mice,doi_bioActivity
10.1021/np070312g,"Moderate antioxidant activities (40–70% at 100 ppm), moderate inhibition of COX-1 (ca. 40%) and marginal inhibition of COX-2 enzymes (<10% at 100 ppm)",doi_bioActivity
10.1021/np070312g,"Moderate antioxidant activity (compared to standard reference compounds), moderate inhibition of lipoperoxidation and COX-1 enzyme (75% and 40% respectively at 100 ppm)",doi_bioActivity
10.1021/np070312g,"Moderate antioxidant activity (compared to standard reference compounds), moderate inhibition of lipoperoxidation and COX-1 enzyme (75% and 58% respectively at 100 ppm)",doi_bioActivity
10.1021/np1007476,"Antioxidant activity, with an IC50 value of 7.50 μM against DPPH free radical scavenging.",doi_bioActivity
10.1021/np1007476,"Antioxidant activity, with an IC50 value of 18.60 μM against DPPH free radical scavenging.",doi_bioActivity
10.1021/np1007476,"Antioxidant activity, with an IC50 value of 18.50 μM against DPPH free radical scavenging.",doi_bioActivity
10.1021/np1007476,"Antioxidant activity, with an IC50 value of 7.50 μM against DPPH free radical scavenging.",doi_bioActivity
10.1021/np1007476,"Antioxidant activity, with an IC50 value of 18.60 μM against DPPH free radical scavenging.",doi_bioActivity
10.1021/np1007476,"Antioxidant activity, with an IC50 value of 18.50 μM against DPPH free radical scavenging.",doi_bioActivity
10.1021/np9703656,Antifungal activity against Cladosporium sphaerospermum,doi_bioActivity
10.1021/np9704617,Moderate antifungal activity against Cladosporium cladosporioides,doi_bioActivity
10.1021/np9704617,"Previously obtained from enzymatic hydrolysis, reported for the first time as a natural product",doi_bioActivity
10.1055/s-2002-36346,"antibacterial activity against Gram-positive bacteria: Staphylococcus aureus, Bacillus cereus, Bacillus subtilis, Bacillus anthracis and Gram-negative bacteria: Klebsiella pneumoniae and fast-acid bacterium Mycobacterium phlei",doi_bioActivity
10.1055/s-2002-36346,"antibacterial activity against Gram-positive bacteria: Staphylococcus aureus, Bacillus cereus, Bacillus subtilis, Bacillus anthracis and Gram-negative bacteria: Klebsiella pneumoniae and fast-acid bacterium Mycobacterium phlei",doi_bioActivity
10.1055/s-2002-36346,"antibacterial activity against Gram-positive bacteria: Staphylococcus aureus, Bacillus cereus, Bacillus subtilis, Bacillus anthracis and Gram-negative bacteria: Klebsiella pneumoniae and fast-acid bacterium Mycobacterium phlei",doi_bioActivity
10.1055/s-2002-36346,"antibacterial activity against Gram-positive bacteria Staphylococcus aureus, Bacillus cereus, Bacillus subtilis, Bacillus anthracis and against Gram-negative bacteria Klebsiella pneumoniae and Pseudomonas termophylla; no inhibition detected at 200 mg/disc for the ethanolic extract; no inhibition detected at 10 mg/disc",doi_bioActivity
10.1080/14786410802243271,Inhibition of epimastigote forms of Trypanosoma cruzi with IC50 value of 15.8 mg/mL,doi_bioActivity
10.1080/14786410802243271,Inhibition of epimastigote forms of Trypanosoma cruzi with IC50 value of 16.3 mg/mL,doi_bioActivity
10.1080/14786410802243271,Inhibition of epimastigote forms of Trypanosoma cruzi with IC50 value of 6.1 mg/mL,doi_bioActivity
10.1080/14786410802243271,Weak inhibition of epimastigote forms of Trypanosoma cruzi with IC50 value of 119.6 mg/mL,doi_bioActivity
10.1080/14786410802243271,Weak inhibition of epimastigote forms of Trypanosoma cruzi with IC50 value of 111.7 mg/mL,doi_bioActivity
10.1080/14786410903335232,"Inhibition of TNF-α induced NF-κB activity; anti-microbial, antioxidant, and cytotoxic properties",doi_bioActivity
10.1080/14786410903335232,Inhibition of TNF-α induced NF-κB activity; greater inhibitory activity than gallic acid,doi_bioActivity
10.1080/14786410903335232,Inhibition of TNF-α induced NF-κB activity,doi_bioActivity
10.1080/14786410903335232,Inhibition of TNF-α induced NF-κB activity,doi_bioActivity
10.1080/14786410903335232,Inhibition of TNF-α induced NF-κB activity,doi_bioActivity
10.1080/14786410903335232,Inhibition of TNF-α induced NF-κB activity; most cytotoxic compound evaluated,doi_bioActivity
10.1080/14786410903335232,Inhibition of TNF-α induced NF-κB activity,doi_bioActivity
10.1080/14786410903335232,Inhibition of TNF-α induced NF-κB activity,doi_bioActivity
10.1080/14786410903335232,Inhibition of TNF-α induced NF-κB activity,doi_bioActivity
10.1107/S1600536803019913,Inhibitor of adenine phosphoribosyltransferase (APRT) enzyme from Leishmania,doi_bioActivity
10.1107/S160053680302107X,Inhibition of adenine phosphoribosyltransferase (APRT) enzyme activity from Leishmania tarentolae,doi_bioActivity
10.1155/2013/835081,Antifungal activity against various Candida species,doi_bioActivity
10.1155/2013/835081,"Broad spectrum of antifungal activity, especially against Candida species with minimum inhibitory concentration values equivalent to the antifungal nystatin",doi_bioActivity
10.1248/bpb.31.538,Trypanocidal agent with IC50 value of 33.8 mM,doi_bioActivity
10.1248/bpb.31.538,Trypanocidal agent with IC50 value of 558.3 mM,doi_bioActivity
10.1248/bpb.31.538,Trypanocidal agent with IC50 value of 190.1 mM,doi_bioActivity
10.1248/bpb.31.538,Trypanocidal agent with IC50 value of 44.8 mM,doi_bioActivity
10.1248/bpb.31.538,Trypanocidal agent with IC50 value of 33.2 mM,doi_bioActivity
10.1248/bpb.31.538,"Trypanocidal agent with IC50 value of 2.82 mM, nearly four times more potent than benznidazole",doi_bioActivity
10.1248/bpb.31.538,Trypanocidal agent with IC50 value of 230.7 mM,doi_bioActivity
10.1248/bpb.31.538,Trypanocidal agent with IC50 value of 22.5 mM,doi_bioActivity
10.1248/bpb.31.538,Trypanocidal agent with IC50 value of 128.5 mM,doi_bioActivity
10.1248/cpb.56.407,"Antinociceptive, semi-synthetic piperidine alkaloid derivatives showing central analgesic activity.",doi_bioActivity
10.1248/cpb.56.407,"Significant antinociceptive activity by inhibiting acetic acid-induced abdominal constrictions with 37% of inhibition, no activity shown in the carrageenan-induced rat paw edema test for anti-inflammatory activity at the dose used.",doi_bioActivity
10.1248/cpb.56.407,"Antinociceptive and anti-inflammatory, inhibited carrageenan-induced rat paw edema with an ED50 value of 56.6 mmol/kg, also acted as a peripheral analgesic.",doi_bioActivity
10.1248/cpb.56.407,"Significant antinociceptive activity, notably in the formalin-induced pain test during the inflammatory phase, suggesting central analgesic activity without anti-inflammatory effects at the tested dose.",doi_bioActivity
10.1248/cpb.56.407,"Series of 2,3,6-trisubstituted piperidine alkaloids showing varying levels of antinociceptive activity.",doi_bioActivity
10.1248/cpb.56.723,MPO inhibitory activity; ABTS and DPPH radical scavenging activity,doi_bioActivity
10.1248/cpb.56.723,MPO inhibitory activity; ABTS and DPPH radical scavenging activity,doi_bioActivity
10.1248/cpb.56.723,ABTS and DPPH radical scavenging activity,doi_bioActivity
10.1248/cpb.56.723,ABTS and DPPH radical scavenging activity,doi_bioActivity
10.1248/cpb.56.723,Most active MPO inhibitor; ABTS and DPPH radical scavenging activity,doi_bioActivity
10.1248/cpb.56.723,ABTS and DPPH radical scavenging activity,doi_bioActivity
10.1248/cpb.56.723,MPO inhibitory activity; ABTS and DPPH radical scavenging activity,doi_bioActivity
10.1248/cpb.56.723,MPO inhibitory activity; ABTS and DPPH radical scavenging activity,doi_bioActivity
10.1248/cpb.56.723,ABTS and DPPH radical scavenging activity,doi_bioActivity
10.1248/cpb.56.723,ABTS and DPPH radical scavenging activity,doi_bioActivity
10.1248/cpb.56.723,Most active MPO inhibitor; ABTS and DPPH radical scavenging activity,doi_bioActivity
10.1248/cpb.56.723,ABTS and DPPH radical scavenging activity,doi_bioActivity
10.1515/znc-2002-5-602,Exhibited activity against insects and potential anticarcinogenic activity including use against tumors like skin cancer,doi_bioActivity
10.1515/znc-2002-5-602,Exhibited activity against insects and potential anticarcinogenic activity,doi_bioActivity
10.1515/znc-2002-5-602,Exhibited activity against insects and potential anticarcinogenic activity,doi_bioActivity
10.1515/znc-2002-5-602,Exhibited activity against insects and potential anticarcinogenic activity including use against tumors like skin cancer,doi_bioActivity
10.1515/znc-2002-5-602,Exhibited activity against insects and potential anticarcinogenic activity,doi_bioActivity
10.1515/znc-2002-5-602,Exhibited activity against insects and potential anticarcinogenic activity,doi_bioActivity
10.1515/znc-2002-5-602,Exhibited activity against insects and potential anticarcinogenic activity including use against tumors like skin cancer,doi_bioActivity
10.1515/znc-2002-5-602,Exhibited activity against insects and potential anticarcinogenic activity,doi_bioActivity
10.1515/znc-2002-5-602,Exhibited activity against insects and potential anticarcinogenic activity,doi_bioActivity
10.1515/znc-2008-5-611,Inhibition of glycosomal glyceraldehyde-3-phosphate dehydrogenase (gGAPDH),doi_bioActivity
10.1515/znc-2008-5-611,Inhibition of gGAPDH and trypanocidal activity,doi_bioActivity
10.1515/znc-2008-5-611,Limited trypanocidal activity; not tested for enzyme inhibition,doi_bioActivity
10.1515/znc-2008-5-611,Not established in this document,doi_bioActivity
10.1515/znc-2008-5-611,Not tested for enzyme inhibition or trypanocidal activity,doi_bioActivity
10.1515/znc-2008-5-611,Not tested for enzyme inhibition or trypanocidal activity,doi_bioActivity
10.1515/znc-2008-5-611,Limited trypanocidal activity; not tested for enzyme inhibition,doi_bioActivity
10.1515/znc-2008-5-611,Inhibition of APRT,doi_bioActivity
10.1515/znc-2008-5-611,Trypanocidal activity against T. cruzi,doi_bioActivity
10.1515/znc-2008-5-611,Inhibition of T. cruzi trypomastigote lysis,doi_bioActivity
10.1515/znc-2008-5-611,Inhibition of TR and strong inhibitory activity on gGAPDH,doi_bioActivity
10.1515/znc-2008-5-611,Inhibition of TR and strong inhibitory activity on gGAPDH,doi_bioActivity
10.1515/znc-2008-5-611,Not tested for enzyme inhibition or trypanocidal activity,doi_bioActivity
10.1515/znc-2008-5-611,Inhibition of gGAPDH and APRT,doi_bioActivity
10.1515/znc-2008-5-611,Inhibition of gGAPDH and APRT,doi_bioActivity
10.1515/znc-2008-5-611,"Inhibition of gGAPDH, APRT, and trypanocidal activity",doi_bioActivity
10.1515/znc-2008-5-611,Inhibition of gGAPDH and APRT,doi_bioActivity
10.1515/znc-2008-5-611,Limited trypanocidal activity; not tested for enzyme inhibition,doi_bioActivity
10.1515/znc-2008-5-611,Inhibition of gGAPDH and APRT,doi_bioActivity
10.1515/znc-2008-5-611,Inhibition of gGAPDH and APRT,doi_bioActivity
10.1515/znc-2008-5-611,Inhibition of gGAPDH and APRT,doi_bioActivity
10.1515/znc-2008-5-611,Inhibition of gGAPDH and APRT,doi_bioActivity
10.1515/znc-2008-5-611,Inhibition of gGAPDH and APRT,doi_bioActivity
10.1515/znc-2008-5-611,Inhibition of gGAPDH,doi_bioActivity
10.1515/znc-2008-5-611,Inhibition of gGAPDH and APRT,doi_bioActivity
10.1515/znc-2008-5-611,Inhibition of gGAPDH and APRT,doi_bioActivity
10.1515/znc-2008-5-611,Not tested for enzyme inhibition or trypanocidal activity,doi_bioActivity
10.1590/S0073-47212009000100009,"Toxicity; Ingestion and topical application tests showed significant mortality rates in worker bees and larvae of Apis mellifera and Scaptotrigona postica, with observable symptoms of intoxication such as sluggish movement, disorientation, leg trembling, paralysis, and eventual death.",doi_bioActivity
10.1590/S0100-40421998000600005,"Inhibition of C. sphaerospermum, fungitoxic activity five times higher than nistatin",doi_bioActivity
10.1590/S0100-40421998000600005,"Inhibition of C. sphaerospermum, fungitoxic activity five times higher than nistatin",doi_bioActivity
10.1590/S0100-40421998000600005,The compound was inactive,doi_bioActivity
10.1590/S0100-40421998000600005,The compound was inactive,doi_bioActivity
10.1590/S0100-40421998000600005,The compound was inactive,doi_bioActivity
10.1590/S0100-40422002000300002,antifungal activity,doi_bioActivity
10.1590/S0100-40422002000300002,inhibitory,doi_bioActivity
10.1590/S0100-40422002000300002,moderate inhibition of mutant strain 52Y of S. cerevisiae indicating specific action on DNA,doi_bioActivity
10.1590/S0100-40422006000300016,antioxidant activity,doi_bioActivity
10.1590/S0100-40422006000300016,antioxidant activity,doi_bioActivity
10.1590/S0100-40422006000300016,antioxidant activity,doi_bioActivity
10.1590/S0100-40422006000300016,antioxidant activity,doi_bioActivity
10.1590/S0100-40422006000300016,antioxidant activity,doi_bioActivity
10.1590/S0100-40422006000300016,antioxidant activity,doi_bioActivity
10.1590/S0100-40422008000400023,Moderate antifungal activity (MIC 100.0 µg/mL),doi_bioActivity
10.1590/S0100-40422008000400023,Moderate antifungal activity (MIC 100.0 µg/mL),doi_bioActivity
10.1590/S0100-40422008000400023,Weak antifungal activity (MIC 200.0 µg/mL),doi_bioActivity
10.1590/S0100-40422008000400023,Inactive,doi_bioActivity
10.1590/S0100-40422012000700020,"In vitro inhibitors of photosynthesis, specifically inhibiting electron transport at several sites of the photosynthetic process, acting as Hill reaction inhibitors",doi_bioActivity
10.1590/S0100-40422012000700020,"In vitro inhibitors of photosynthesis, similar to Molecule_1, they participate in the creation of 'silent reaction centers' by interfering with water photolysis",doi_bioActivity
10.1590/S0102-695X2007000300003,Weak antibacterial activity against Gram-positive bacteria S. aureus and B. subtilis. Weak scavenging activity with IC50 of 50.0 µM against DPPH free radical.,doi_bioActivity
10.1590/S0102-695X2007000300003,Weak antibacterial activity against Gram-positive bacteria S. aureus and B. subtilis. Weak scavenging activity with IC50 of 40.7 µM against DPPH free radical.,doi_bioActivity
10.1590/S0102-695X2007000300003,Weak antibacterial activity against Gram-positive bacteria S. aureus and B. subtilis. Weak scavenging activity with IC50 of 35.4 µM against DPPH free radical.,doi_bioActivity
10.1590/S0102-695X2007000300003,Weak antibacterial activity against Gram-positive bacteria S. aureus and B. subtilis. Moderate scavenging activity with IC50 of 18.5 µM against DPPH free radical.,doi_bioActivity
10.1590/S0103-50532002000100010,Antifungal activity against Leucoagaricus gongylophorus; inactive or weak inhibitory activity against Trypanosoma cruzi trypomastigote forms,doi_bioActivity
10.1590/S0103-50532002000100010,Antifungal activity against Leucoagaricus gongylophorus; inactive or weak inhibitory activity against Trypanosoma cruzi trypomastigote forms,doi_bioActivity
10.1590/S0103-50532002000100010,Antifungal activity against Leucoagaricus gongylophorus; inactive or weak inhibitory activity against Trypanosoma cruzi trypomastigote forms,doi_bioActivity
10.1590/S0103-50532002000100010,Antifungal activity against Leucoagaricus gongylophorus,doi_bioActivity
10.1590/S0103-50532002000100010,Some moderate activity on trypomastigote forms of Trypanosoma cruzi; antifungal activity not explicitly described in provided extract,doi_bioActivity
10.1590/S0103-50532002000100010,Some moderate activity on trypomastigote forms of Trypanosoma cruzi; antifungal activity not explicitly described in provided extract,doi_bioActivity
10.1590/S0103-50532002000100010,Biological activities not described in provided extract; inactive or weak inhibitory activity against Trypanosoma cruzi trypomastigote forms,doi_bioActivity
10.1590/S0103-50532002000100010,Antifungal activity against Leucoagaricus gongylophorus; inactive or weak inhibitory activity against Trypanosoma cruzi trypomastigote forms,doi_bioActivity
10.1590/S0103-50532002000100010,Antifungal activity against Leucoagaricus gongylophorus; inactive or weak inhibitory activity against Trypanosoma cruzi trypomastigote forms,doi_bioActivity
10.1590/S0103-50532002000100010,Antifungal activity against Leucoagaricus gongylophorus; inactive or weak inhibitory activity against Trypanosoma cruzi trypomastigote forms,doi_bioActivity
10.1590/S0103-50532002000100010,Antifungal activity against Leucoagaricus gongylophorus,doi_bioActivity
10.1590/S0103-50532002000100010,Some moderate activity on trypomastigote forms of Trypanosoma cruzi; antifungal activity not explicitly described in provided extract,doi_bioActivity
10.1590/S0103-50532002000100010,Some moderate activity on trypomastigote forms of Trypanosoma cruzi; antifungal activity not explicitly described in provided extract,doi_bioActivity
10.1590/S0103-50532002000100010,Biological activities not described in provided extract; inactive or weak inhibitory activity against Trypanosoma cruzi trypomastigote forms,doi_bioActivity
10.1590/S0103-50532002000100019,"Insecticidal activity against Apis mellifera (honeybees), reduces average survival of treated bees",doi_bioActivity
10.1590/S0103-50532002000100019,"Possible insecticidal activity, further bioassays needed to confirm individual activity",doi_bioActivity
10.1590/S0103-50532002000100019,"Possible insecticidal activity, further bioassays needed to confirm individual activity",doi_bioActivity
10.1590/S0103-50532003000500012,Antioxidant activity,doi_bioActivity
10.1590/S0103-50532003000500012,Antioxidant activity,doi_bioActivity
10.1590/S0103-50532003000500012,Antioxidant activity,doi_bioActivity
10.1590/S0103-50532005000400031,Moderate inhibition (40% at 72 µg mL-1) of the symbiotic fungus of leaf-cutting ant Atta sexdens,doi_bioActivity
10.1590/S0103-50532005000400031,Total inhibition (100% at 64 µg mL-1) of the symbiotic fungus of leaf-cutting ant Atta sexdens,doi_bioActivity
10.1590/S0103-50532005000400031,Total inhibition (100% at 70 µg mL-1) of the symbiotic fungus of leaf-cutting ant Atta sexdens,doi_bioActivity
10.1590/S0103-50532005000400031,No effect on the fungal development at a concentration of 75 µg mL-1,doi_bioActivity
10.1590/S0103-50532005000400031,Total inhibition (100% at 80 µg mL-1) of the symbiotic fungus of leaf-cutting ant Atta sexdens,doi_bioActivity
10.1590/S0103-50532005000400031,Moderate inhibition (60% at 65 µg mL-1) of the symbiotic fungus of leaf-cutting ant Atta sexdens,doi_bioActivity
10.1590/S0103-50532005000400031,Total inhibition (100% at 25 µg mL-1) of the symbiotic fungus of leaf-cutting ant Atta sexdens,doi_bioActivity
10.1590/S0103-50532005000400031,Strong inhibition (80% at 75 µg mL-1) of the symbiotic fungus of leaf-cutting ant Atta sexdens,doi_bioActivity
10.1590/S0103-50532005000800025,Ichthyotoxic and insect antifeedant activities against Oryzias latipes and Spodoptera littoralis,doi_bioActivity
10.1590/S0103-50532005000800025,Insect antifeedant activities,doi_bioActivity
10.1590/S0103-50532005000800025,No toxicity to the leaf-cutting ants Atta sexdens rubropilosa,doi_bioActivity
10.1590/S0103-50532005000800025,High toxicity to the leaf-cutting ants Atta sexdens rubropilosa,doi_bioActivity
10.1590/S0103-50532005000800025,Ichthyotoxic and insect antifeedant activities against Oryzias latipes and Spodoptera littoralis,doi_bioActivity
10.1590/S0103-50532005000800025,Insect antifeedant activities,doi_bioActivity
10.1590/S0103-50532005000800025,No toxicity to the leaf-cutting ants Atta sexdens rubropilosa,doi_bioActivity
10.1590/S0103-50532005000800025,High toxicity to the leaf-cutting ants Atta sexdens rubropilosa,doi_bioActivity
10.1590/S0103-50532005000800029,"Antifungal activity against Cladosporium cladosporioides and C. sphaerospermum, and cytotoxicity against human cervical tumor cell line (HeLa) in vitro",doi_bioActivity
10.1590/S0103-50532005000800029,"Antifungal activity against Cladosporium cladosporioides and C. sphaerospermum, weak cytotoxicity against human cervical tumor cell line (HeLa) in vitro",doi_bioActivity
10.1590/S0103-50532005000800029,Strong cytotoxicity against human cervical tumor cell line (HeLa) in vitro,doi_bioActivity
10.1590/S0103-50532005000800029,"Antifungal activity against Cladosporium cladosporioides and C. sphaerospermum, and cytotoxicity against human cervical tumor cell line (HeLa) in vitro",doi_bioActivity
10.1590/S0103-50532005000800029,"Antifungal activity against Cladosporium cladosporioides and C. sphaerospermum, weak cytotoxicity against human cervical tumor cell line (HeLa) in vitro",doi_bioActivity
10.1590/S0103-50532005000800029,Strong cytotoxicity against human cervical tumor cell line (HeLa) in vitro,doi_bioActivity
10.1590/S0103-50532007000700017,"Antifungal activity, moderate activity with MIC of 100 μg compared to standard nystatin with 1.0 μg",doi_bioActivity
10.1590/S0103-50532007000700017,"Antifungal activity, moderate activity with MIC of 100 μg compared to standard nystatin with 1.0 μg",doi_bioActivity
10.1590/S0103-50532009000100029,Trypanocidal activity with IC50 of 9.8 µmol L-1 against Trypanosoma cruzi,doi_bioActivity
10.1590/S0103-50532009000100029,Trypanocidal activity with IC50 of 3.7 µmol L-1 against Trypanosoma cruzi,doi_bioActivity
10.1590/S1519-566X2008000600013,"Increase in larval mortality, elongation of larval development time, and reduction in larval survival",doi_bioActivity
10.1590/S1519-566X2008000600013,Less effective than other compounds against T. absoluta,doi_bioActivity
10.1590/S1519-566X2008000600013,Less effective than other compounds against T. absoluta,doi_bioActivity
10.1590/S1519-566X2008000600013,"Among the most effective against T. absoluta, causing prolongation of larval development and reduction in larval survival",doi_bioActivity
10.1590/S1519-566X2008000600013,Less effective than other compounds against T. absoluta,doi_bioActivity
10.1590/S1519-566X2008000600013,Less effective than other compounds against T. absoluta,doi_bioActivity
10.1590/S1519-566X2008000600013,"Among the most effective against T. absoluta, causing prolongation of larval development and reduction in larval survival",doi_bioActivity
10.2174/187152010794728620,induced a cell cycle arrest in the G1 phase,doi_bioActivity
10.2174/187152010794728620,caused cell cycle arrest in the S phase and was a potent inducer of programmed cell death,doi_bioActivity
10.2174/187152010794728620,did not affect the cell cycle profile but caused a very small increase in cell death,doi_bioActivity
10.2174/187152010794728620,arrested cell cycle at the S and G2M phases and was a very potent inducer of programmed cell death,doi_bioActivity
10.2174/187152010794728620,moderate activity in inhibiting tumor cell growth,doi_bioActivity
10.2174/187152010794728620,"did not exhibit cytotoxicity against certain tumor cell lines, possible MDR-reversing effects in presence of colchicine",doi_bioActivity
10.2174/187152010794728620,moderate growth inhibitory activity against MCF-7 and NCI-H460 cells but strong activity against A375-C5 cells,doi_bioActivity
10.2174/187152010794728620,moderate growth inhibitory activity against certain tumor cell lines,doi_bioActivity
10.2174/187152010794728620,weak inhibitory activity against tumor cell lines,doi_bioActivity
10.2174/187152010794728620,inactive against three human tumor cell lines tested,doi_bioActivity
10.2174/187152010794728620,inactive against three human tumor cell lines tested,doi_bioActivity
10.2174/187152010794728620,"inactive against three human tumor cell lines tested, moderate antiproliferative activity in breast cancer cell lines",doi_bioActivity
10.2174/187152010794728620,inactive against three human tumor cell lines tested,doi_bioActivity
